Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for constructing disease model on basis of gene operation strategy and application

A disease model and gene manipulation technology, applied in animal husbandry and other fields, can solve problems such as difficult diagnosis, lack of pathogenesis, and complicated and complicated disease-causing genes

Active Publication Date: 2019-08-09
SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL
View PDF7 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, its clinical involvement is wide, and there is a large overlap of clinical phenotypes among various types, making clinical typing very difficult. Therefore, the final diagnosis of cerebellar ataxia must rely on genetic testing
However, due to the large number of types and the complexity of the pathogenic genes, it brings great difficulties to the diagnosis
At present, there is still a lack of specific and effective treatments for cerebellar ataxia, the main reason being the lack of detailed pathogenesis studies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for constructing disease model on basis of gene operation strategy and application
  • Method for constructing disease model on basis of gene operation strategy and application
  • Method for constructing disease model on basis of gene operation strategy and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] Mutation of mouse Emc3 gene by CRISPR / Cas9 technology

[0079] 1 Design the gRNA sequence targeting knockout of the Emc3 gene, and obtain the F0 generation of Emc3 gene conditional knockout mice. The gRNA sequence was designed for the second exon region of the mouse Emc3 gene: 5'-CCTTTGTGAAAACCTGTGTGGCA-3'. Synthesize RNA in vitro, microinject into mouse fertilized eggs together with Cas9 protein and repair DNA template, and obtain the first founder mouse (founder) with gene mutation; the schematic diagram of CRISPR design is as follows figure 1 shown. Repair DNA template sequence: DNA repair template sequence is as follows (SEQ ID NO.1):

[0080]CcttcctcagaaacctttatttgttcagagcccagtcactctggaagactgccttggatccATAACTTCGTATAATGTATGCTATA CGAAGTTATggctgtgaaaacctgtgtggcaagttgaatatgtttcattgatttttagggtttttggaaagtttccacacccagcttttgccaaccaggtcc tcccttatgtctgagtgggccttctactttacgcttgctttctttgcgtttcacattttaacatctctttgtcttgtgtttttcagTCAGGTCCTAATTCGA AGCAGAGTCCTCAGGGAAAATGGAAAATACATTC...

Embodiment 2

[0082] Knockout of mouse Emc3 gene by Cre-loxp gene knockout technology

[0083] 1. Using mice as the target animals, the Cre-loxp conditional knockout system was used to construct a mouse model of retinal neovascular disease.

[0084] (1) mice carrying the loxp sequence (Emc3 loxp / loxp ) is mated with a tool mouse carrying Pdgfb-Cre specifically expressed in vascular endothelial cells to obtain a mouse carrying loxp sequence and Cre at the same time, expressed as Emc3 loxp / + -Pdgfb-Cre, followed by Emc3 loxp / loxp with Emc3 loxp / + -Pdgfb-Cre mice were mated to obtain Emc3 loxp / loxp-Pdgfb-Cre mice ( figure 2 Middle A, image 3 ).

[0085] The mouse Emc3 genome sequence is shown in SEQ ID NO.2. Among them, the 501-825th position is the first exon, the 9346-9403rd position is the second exon, the 9746-9839th position is the third exon, and the 11572-11676th position is the fourth exon, The 12157-12238 position is the fifth exon, the 14192-14271 position is the sixth exon...

Embodiment 3

[0109] Staining of frozen sections of eyeballs and separation of hyaloids.

[0110] (1) Eyeball frozen section preparation: after the mice were killed, the eyeballs were put into 4% PFA solution and fixed at room temperature for 20 minutes, then a 30G needle was used to pierce a hole in the center of the cornea, and the entire cornea was cut off with ophthalmic scissors. The fixed eyeballs were rinsed once with 1×PBS, placed in 30% 1×PBS sucrose solution, and dehydrated at 4°C for 2 hours. Then the lens of the eyeball was taken out, the water was blotted, and the eyeball was placed in a frozen section embedding box equipped with OCT in the same direction, and after being solidified at -80°C, it was stored at -20°C. All sections were 10 μm thick.

[0111](2) Vitreous vessel separation: Take mouse eyeballs, place them in a 24-well plate filled with 4% PFA and fix them at room temperature for 15 minutes, then perforate the cornea and completely remove the corneas, and continue t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Thicknessaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for constructing a disease model on the basis of a gene operation strategy and application, and relates to the technical field of biology. According to the method, anEmc3 gene is prevented from being expressed in vascular endothelial cells or cerebellum Purkinje cells of a target animal through a gene operation technology. By using the method, a disease animal model showing typical characteristics of retinal neovascularization diseases or cerebellar ataxia diseases can be obtained. The method provides a new thought or strategy for constructing a retinal neovascularization disease model or a cerebellar ataxia disease model. In addition, the disease model obtained by means of the method also provides a model basis for science researchers to study the retinalneovascularization diseases and screen medicines for treating the retinal neovascularization diseases or the cerebellar ataxia diseases.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a method and application for constructing a disease model based on a gene manipulation strategy. Background technique [0002] Retinal neovascular disease is one of the serious blinding eye diseases in my country and even in the world. It mainly refers to the blinding vitreoretinal disease caused by the growth of new blood vessels accompanied by pathological changes such as hemorrhage, exudation, and proliferation. Including diabetic retinopathy, retinal vascular occlusive disease, retinal periphlebitis, retinopathy of prematurity, etc., the threat to the visual health of the Chinese population has become increasingly prominent. For a long time, there are different opinions on the mechanism of retinal neovascularization. Therefore, it is of great clinical significance to carry out research on the immunological mechanism related to retinal neovascular diseases in order to find target...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A01K67/02
CPCA01K67/02
Inventor 朱献军朱雄杨牧李姝锦杨业明刘文静孙宽祥
Owner SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com